AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from the ...
Tomo’s online rates comparison tool is among the best we’ve seen for shopping rates — and both their rates and fees are competitive. While they don’t offer refinance or home equity options, the solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results